is an Associate Professor of Algorithmic Machine Learning & Explainable AI at TU Munich and senior PI at Helmholtz AI.
He works on developing algorithms that learn causal relationships from high-dimensional inputs, explain their decisions, and adapt quickly to new problems. All these requirements are key prerequisites for robust and transformative AI-based technologies with various downstream applications.
Causal machine learning (ML) offers flexible, data-driven methods for predicting treatment outcomes including efficacy and toxicity, thereby supporting the assessment and safety of drugs. A key benefit of causal ML is that it allows for estimating individualized treatment effects, so that clinical decision-making can be personalized to individual patient profiles. Causal ML can be used in combination with both clinical trial data and real-world data, such as clinical registries and electronic health records, but caution is needed to avoid biased or incorrect predictions. In this Perspective, we discuss the benefits of causal ML (relative to traditional statistical or ML approaches) and outline the key components and steps. Finally, we provide recommendations for the reliable use of causal ML and effective translation into the clinic.
©all images: LMU | TUM